- Home
- ASBP vs IMCC Comparison
ASBP vs IMCC Comparison
Compare ASBP & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASBP
- IMCC
- Stock Information
- Founded
- ASBP 2021
- IMCC 1980
- Country
- ASBP United States
- IMCC Israel
- Employees
- ASBP N/A
- IMCC N/A
- Industry
- ASBP Biotechnology: Pharmaceutical Preparations
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- ASBP Health Care
- IMCC Health Care
- Exchange
- ASBP Nasdaq
- IMCC Nasdaq
- Market Cap
- ASBP 14.5M
- IMCC 11.8M
- IPO Year
- ASBP N/A
- IMCC N/A
- Fundamental
- Price
- ASBP $0.39
- IMCC $3.06
- Analyst Decision
- ASBP
- IMCC
- Analyst Count
- ASBP 0
- IMCC 0
- Target Price
- ASBP N/A
- IMCC N/A
- AVG Volume (30 Days)
- ASBP 7.8M
- IMCC 73.1K
- Earning Date
- ASBP 08-24-2025
- IMCC 08-13-2025
- Dividend Yield
- ASBP N/A
- IMCC N/A
- EPS Growth
- ASBP N/A
- IMCC N/A
- EPS
- ASBP N/A
- IMCC N/A
- Revenue
- ASBP N/A
- IMCC $37,894,737.00
- Revenue This Year
- ASBP N/A
- IMCC $47.12
- Revenue Next Year
- ASBP N/A
- IMCC $12.83
- P/E Ratio
- ASBP N/A
- IMCC N/A
- Revenue Growth
- ASBP N/A
- IMCC 12.68
- 52 Week Low
- ASBP $0.22
- IMCC $1.29
- 52 Week High
- ASBP $15.80
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- ASBP N/A
- IMCC 52.87
- Support Level
- ASBP N/A
- IMCC $3.03
- Resistance Level
- ASBP N/A
- IMCC $3.61
- Average True Range (ATR)
- ASBP 0.00
- IMCC 0.37
- MACD
- ASBP 0.00
- IMCC -0.02
- Stochastic Oscillator
- ASBP 0.00
- IMCC 50.43
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.